Annual Shareholders Equity
$3.75 M
+$5.10 M+378.48%
December 31, 2023
Summary
- As of February 8, 2025, PMN annual stockholders equity is $3.75 million, with the most recent change of +$5.10 million (+378.48%) on December 31, 2023.
- During the last 3 years, PMN annual shareholders equity has risen by +$4.55 million (+571.11%).
- PMN annual shareholders equity is now -69.23% below its all-time high of $12.20 million, reached on March 1, 2007.
Performance
PMN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$7.27 M
+$9.55 M+419.41%
September 30, 2024
Summary
- As of February 8, 2025, PMN quarterly stockholders equity is $7.27 million, with the most recent change of +$9.55 million (+419.41%) on September 30, 2024.
- Over the past year, PMN quarterly shareholders equity has increased by +$518.30 thousand (+7.67%).
- PMN quarterly shareholders equity is now -40.37% below its all-time high of $12.20 million, reached on March 1, 2007.
Performance
PMN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PMN Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +378.5% | +7.7% |
3 y3 years | +571.1% | +896.6% |
5 y5 years | +342.1% | +205.7% |
PMN Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -33.7% | +378.5% | at high | +185.3% |
5 y | 5-year | -33.7% | +378.5% | -3.6% | +185.3% |
alltime | all time | -69.2% | +378.5% | -40.4% | +185.3% |
ProMIS Neurosciences Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $7.27 M(-419.4%) |
Jun 2024 | - | -$2.28 M(-3053.4%) |
Mar 2024 | - | $77.10 K(-97.9%) |
Dec 2023 | $3.75 M(-378.5%) | $3.75 M(-44.4%) |
Sep 2023 | - | $6.75 M(-179.2%) |
Jun 2023 | - | -$8.53 M(+38.0%) |
Mar 2023 | - | -$6.18 M(+358.5%) |
Dec 2022 | -$1.35 M(-123.8%) | -$1.35 M(-284.7%) |
Sep 2022 | - | $729.80 K(-89.1%) |
Jun 2022 | - | $6.71 M(+79.5%) |
Mar 2022 | - | $3.74 M(-33.9%) |
Dec 2021 | $5.66 M(-810.4%) | $5.66 M(-25.0%) |
Sep 2021 | - | $7.54 M(-206.3%) |
Jun 2021 | - | -$7.10 M(+3.2%) |
Mar 2021 | - | -$6.88 M(+763.5%) |
Dec 2020 | -$796.70 K(-361.4%) | -$796.70 K(-47.8%) |
Sep 2020 | - | -$1.53 M(+293.1%) |
Jun 2020 | - | -$388.10 K(+184.1%) |
Mar 2020 | - | -$136.60 K(-144.8%) |
Dec 2019 | $304.80 K(-64.1%) | - |
Dec 2019 | - | $304.80 K(-142.0%) |
Sep 2019 | - | -$725.10 K(-274.7%) |
Jun 2019 | - | $415.10 K(-52.1%) |
Mar 2019 | - | $867.40 K(+2.2%) |
Dec 2018 | $848.90 K(-30.4%) | - |
Dec 2018 | - | $848.90 K(-75.3%) |
Sep 2018 | - | $3.44 M(-33.1%) |
Jun 2018 | - | $5.15 M(+258.8%) |
Mar 2018 | - | $1.43 M(+17.6%) |
Dec 2017 | $1.22 M(+2258.6%) | $1.22 M(-41.8%) |
Sep 2017 | - | $2.10 M(-3681.9%) |
Jun 2017 | - | -$58.50 K(-104.7%) |
Mar 2017 | - | $1.24 M(+2292.3%) |
Dec 2016 | $51.70 K(-88.0%) | $51.70 K(-93.8%) |
Sep 2016 | - | $833.30 K(+181.4%) |
Jun 2016 | - | $296.10 K(-38.6%) |
Mar 2016 | - | $482.30 K(+11.5%) |
Dec 2015 | $432.40 K(-353.2%) | $432.40 K(-47.1%) |
Sep 2015 | - | $817.90 K(-213.7%) |
Jun 2015 | - | -$719.50 K(+45.8%) |
Mar 2015 | - | -$493.50 K(+570.5%) |
Dec 2014 | -$170.80 K | - |
Sep 2014 | - | -$73.60 K(-118.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2014 | - | $402.70 K(+8654.3%) |
Mar 2014 | $4600.00(-102.2%) | $4600.00(-101.0%) |
Dec 2013 | - | -$483.40 K(+46.6%) |
Sep 2013 | - | -$329.80 K(-1199.3%) |
Jun 2013 | - | $30.00 K(-114.1%) |
Mar 2013 | -$212.50 K(-126.2%) | -$212.50 K(-237.9%) |
Dec 2012 | - | $154.10 K(-76.5%) |
Sep 2012 | - | $654.60 K(-44.5%) |
Jun 2012 | - | $1.18 M(+45.4%) |
Mar 2012 | $810.90 K(-67.2%) | $810.90 K(+18.8%) |
Dec 2011 | - | $682.80 K(-47.1%) |
Sep 2011 | - | $1.29 M(-34.3%) |
Jun 2011 | - | $1.96 M(-20.6%) |
Mar 2011 | $2.47 M(-47.1%) | $2.47 M(-5.9%) |
Dec 2010 | - | $2.63 M(-19.3%) |
Sep 2010 | - | $3.26 M(+7.6%) |
Jun 2010 | - | $3.02 M(-35.2%) |
Mar 2010 | $4.67 M(+19.9%) | $4.67 M(-14.3%) |
Dec 2009 | - | $5.45 M(-7.8%) |
Sep 2009 | - | $5.91 M(-2.7%) |
Jun 2009 | - | $6.07 M(+55.8%) |
Mar 2009 | $3.90 M(-53.9%) | $3.90 M(-19.0%) |
Dec 2008 | - | $4.81 M(-20.1%) |
Sep 2008 | - | $6.03 M(-16.0%) |
Jun 2008 | - | $7.18 M(-15.1%) |
Mar 2008 | $8.45 M(-30.7%) | $8.45 M(-19.2%) |
Dec 2007 | - | $10.45 M(-10.4%) |
Sep 2007 | - | $11.66 M(-3.9%) |
Jun 2007 | - | $12.13 M(-0.6%) |
Mar 2007 | $12.20 M(+168.3%) | $12.20 M(+135.1%) |
Dec 2006 | - | $5.19 M(-1.1%) |
Sep 2006 | - | $5.24 M(+9.6%) |
Jun 2006 | - | $4.78 M(+5.2%) |
Mar 2006 | $4.55 M | $4.55 M(+121.0%) |
Dec 2005 | - | $2.06 M(-12.0%) |
Sep 2005 | - | $2.34 M(+745.7%) |
Jun 2005 | - | $276.20 K(+145.5%) |
Dec 2002 | - | $112.50 K(-24.0%) |
Jun 2002 | - | $148.10 K(-303.2%) |
Dec 2001 | - | -$72.90 K(-417.0%) |
Jun 2001 | - | $23.00 K(-75.7%) |
Dec 2000 | - | $94.60 K(-79.1%) |
Jun 2000 | - | $452.70 K |
FAQ
- What is ProMIS Neurosciences annual stockholders equity?
- What is the all time high annual shareholders equity for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual shareholders equity year-on-year change?
- What is ProMIS Neurosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly shareholders equity year-on-year change?
What is ProMIS Neurosciences annual stockholders equity?
The current annual shareholders equity of PMN is $3.75 M
What is the all time high annual shareholders equity for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual stockholders equity is $12.20 M
What is ProMIS Neurosciences annual shareholders equity year-on-year change?
Over the past year, PMN annual stockholders equity has changed by +$5.10 M (+378.48%)
What is ProMIS Neurosciences quarterly stockholders equity?
The current quarterly shareholders equity of PMN is $7.27 M
What is the all time high quarterly shareholders equity for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly stockholders equity is $12.20 M
What is ProMIS Neurosciences quarterly shareholders equity year-on-year change?
Over the past year, PMN quarterly stockholders equity has changed by +$518.30 K (+7.67%)